PDF herunterladen
kleintier konkret 2011; 14(S 01): 29-32
DOI: 10.1055/s-0030-1267795
Hund und Katze
Schmerztherapie
Enke Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Klinische Anwendung von Robenacoxib (Onsior®) bei Hund und Katze

Sabine Tacke
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. März 2011 (online)

Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Tiere leiden genauso unter Schmerzen wie Menschen. Allerdings ist es oft nicht so einfach, Schmerzen beim Tier sofort zu erkennen. Die Notwendigkeit einer erfolgreichen, dem aktuellen Zustand des Patienten angepassten Schmerztherapie ist in den letzten Jahren immer mehr in den Fokus gerückt. Dies hat zur Entwicklung und Zulassung einer Vielzahl von Analgetika geführt. Zu diesen Präparaten zählt auch das nichtsteroidale Antiphlogistikum (NSAID) Robenacoxib aus der Klasse der Coxibe.

 

  • Literatur

  • 1 Edwards SHR. Intra-articular drug delivery: The challenge to extend drug residence time within the joint. The Veterinary Journal. (in press)
    Google Scholar
  • 2 EMEA Robenacoxib – Scientific discussion. London: Committee for Veterinary Medicinal Products, European Agency for the Evaluation of Medicinal Products; 2008 http://www.emea.europa.eu
    Google Scholar
  • 3 Giraudel JM, King JN, Jeunesse EC et al. Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib. J Vet Pharmacol Ther 2009; 32: 18-30
    Google Scholar
  • 4 Giraudel JM, Toutain PL, King JN et al. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib. J Vet Pharmacol Ther 2009; 32: 31-40
    Google Scholar
  • 5 Giraudel J, Peyrou M, King JN et al. Population pharmacokinetic analysis of blood robenacoxib data from two dose confirmation field studies in dogs with osteoarthritis. J Vet Pharmacol Ther 2009; 32: 102-103
    Google Scholar
  • 6 Giraudel JM, Gruet P, Alexander DG et al. Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats. Am J Vet Res 2010; 71: 710-719
    Google Scholar
  • 7 Grubb T. Where Do We Go from Here? Future Treatment Strategies for Chronic Pain. Topics in Companion Animal Medicine 2010; 25: 59-63
    Google Scholar
  • 8 Gruet P, Seewald W, King JN. Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs. Am J Vet Res 2011; 72: 184-193
    Google Scholar
  • 9 Jung M, Lees P, Seewald W et al. Analytical determination and pharmacokinetics of robenacoxib in the dog. J Vet Pharmacol Ther 2009; 32: 41-48
    Google Scholar
  • 10 King JN, Dawson J, Esser RE et al. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. J Vet Pharmacol Ther 2009; 32: 1-17
    Google Scholar
  • 11 King JN, Rudaz C, Borer L et al. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. Res Vet Sci 2010; 88: 497-506
    Google Scholar
  • 12 Lascelles BD, Hansen BD, Roe S et al. Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med 2007; 213: 410-416
    Google Scholar
  • 13 Lascelles BD. Feline degenerative joint disease. Vet Surg 2010; 391: 2-13
    Google Scholar
  • 14 Lascelles BD, Robertson SA. DJD-Associated pain in cats: What can we do to promote patient comfort?. J Feline Med Surg 2010; 12: 200-212
    Google Scholar
  • 15 Marshall JF, Bhatnagar AS, Bowman SG et al. Evaluation of the cyclooxygenase selectivity of robenacoxib and its effect on recovery of ischemia-injured jejunal mucosa in horses. Am J Vet Res 2011; 72: 226-232
    Google Scholar
  • 16 Robertson SA, Lascelles BD. Long-term pain in cats: how much do we know about this important welfare issue?. J Feline Med Surg 2010; 12: 188-199
    Google Scholar
  • 17 Schmid VB, Seewald W, Lees P et al. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. J Vet Pharmacol Ther 2010; 33: 444-452
    Google Scholar
  • 18 Schmid VB, Spreng DE, Seewald W et al. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. J Vet Pharmacol Ther 2010; 33: 118-131
    Google Scholar
  • 19 Silber HE, Burgener C, Letellier IM et al. Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis. Pharm Res 2010; 27: 2633-2645
    Google Scholar
  • 20 Sparkes AH, Heiene R, Lascelles BD et al. ISFM and AAFP consensus guidelines: long-term use of NSAIDs in cats. J Feline Med Surg 2010; 127: 521-538
    Google Scholar
  • 21 VETIDATA www.vetidata.de. Letzter Zugriff: 13.02.2011